Drawing for PETBEX

USPTO serial 79403242

PETBEX

Reviewed by CopyMark Law Group

Reg. 7979717Status 700Registered
Filing date
Status date
Registration date
Oct 14, 2025
Examiner
FRUM MILONE, MARCIE R
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with PETBEX?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Kisuk Lee

Kisuk Lee Harness, Dickey & Pierce, PLC7700 Bonhomme Ave, Suite 400St. Louis, MO 63105United States

Goods and services

ClassDescriptionStatusFirst use
005Veterinary preparations for companion animals and non-companion working animals for treatment of inflammatory conditions, including metabolic, autoimmune, and geriatric diseases, and for preserving, supporting, or restoring the function of damaged tissues or organs to promote recovery and normal physiological function; veterinary vaccines; medicated skin treatment for animals in the nature of pharmaceutical preparations for animal skincare for the treatment of dermatitis and wound healing; food supplements for veterinary purposes; medical foodstuff additives for veterinary use for improving nutrition and immune function in animals; biological preparations for medical or veterinary purposes being biological reagents for therapeutic use in animals; biochemical preparations for medical or veterinary purposes being biological reagents for therapeutic use in animals; medicated animal feed; veterinary preparations for treatment of intestinal bacteria; pharmaceutical drugs being pharmaceutical preparations for the treatment of inflammatory conditions, including metabolic, autoimmune, and geriatric diseases, and for preserving, supporting, or restoring the function of damaged tissues or organs to promote recovery and normal physiological function.ACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
May 14, 2026FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Apr 29, 2026FICSFINAL DISPOSITION NOTICE SENT TO IB—
Apr 29, 2026FIMPFINAL DISPOSITION PROCESSED—
Feb 12, 2026OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Jan 27, 2026OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Jan 27, 2026OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Jan 14, 2026FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Oct 14, 2025NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Oct 14, 2025R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Aug 26, 2025NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Aug 26, 2025PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Aug 20, 2025NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jul 18, 2025CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jul 18, 2025XAECEXAMINER'S AMENDMENT ENTERED—
Jul 18, 2025GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Jul 18, 2025GNEAEXAMINERS AMENDMENT E-MAILED—
Jul 18, 2025CNEAEXAMINERS AMENDMENT -WRITTEN—
Jul 15, 2025TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jul 15, 2025CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jul 15, 2025TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 15, 2025ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 15, 2025REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jul 15, 2025CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Jul 15, 2025COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Apr 4, 2025RFNTREFUSAL PROCESSED BY IB—
Mar 19, 2025RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Mar 19, 2025RFRRREFUSAL PROCESSED BY MPU—
Feb 12, 2025RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Feb 11, 2025CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 29, 2024DOCKASSIGNED TO EXAMINER—
Sep 4, 2024MAFRAPPLICATION FILING RECEIPT MAILED—
Sep 4, 2024NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Aug 29, 2024REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance